01 (Image 01)
Nifedipine Tablet, Film Coated, Extended Release
Product Images NDC 50742-261
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 50742-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
02 (Image 02)
The text provides information on the adverse effects of Nifedipine extended-release tablets and placebo. The adverse effects associated with Nifedipine extended-release tablets as reported were headache, fatigue, dizziness, constipation, and nausea. The corresponding percentages of these adverse effects were 15.8%, 5.9%, 4.1%, 3.3% and 33% respectively. Similarly, the adverse effects associated with Placebo were headache, fatigue, dizziness, constipation, and nausea while the corresponding percentages were 9.8%, 4.1%, 4.5%, 23%, and 19%.*
03 (Image 03)
This is a table comparing the incidence of adverse effects in patients taking Nifedipine Capsules versus a placebo. The adverse effects listed include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat. Percentages are reported for each adverse effect in the two groups of patients, each consisting of 226 and 235 individuals.*
04 (Image 04)
05 (Image 05)
This is a description of extended-release tablets of Nifedipine that are available in a packing of 100 tablets. Each tablet has 30mg of Nifedipine, USP. The prescription drug should be taken as recommended in the package insert. The tablets should be store in a dry and cool place and protected from light. The pharmacist should place them in a tight, light-resistant container. The package comes with a warning to keep the tablets away from children. Some of the package details like the expiration date and SN number are not available.*
06 (Image 06)
07 (Image 07)
This is a description of Nifedipine Extended-Release Tablets, used as medication. Each coated tablet contains 90 mg of Nifedipine and must not be bitten or divided when consumed. The medication should be stored in a tight container at room temperature and protected from light and moisture. Pharmacist assistance is required to dispense it. The tablets should be kept away from children. The other details about the product are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
